Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 15/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 15/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 14/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12428121 | 0.81 | KAT8 (0.45) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL12428259 | 0.81 | SCN9A (0.39) | OPRM1OPRK1OPRD1ACHEMEN1 | |
| SCHEMBL12428197 | 0.78 | KMT2A (0.48) | OPRK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL12428192 | 0.77 | KAT8 (0.43) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL12428272 | 0.77 | SCN9A (0.36) | OPRM1OPRK1OPRD1ACHEMEN1 | |
| SCHEMBL12428202 | 0.77 | KAT8 (0.43) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL12428236 | 0.76 | MAPT (0.46) | OPRK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL12428331 | 0.76 | KMT2A (0.47) | OPRK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL12428368 | 0.75 | OPRM1 (0.42) | OPRM1OPRK1OPRD1ACHEMEN1 | |
| SCHEMBL12428249 | 0.75 | EP300 (0.41) | ACHEMEN1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977570-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977570-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-1885015-A1 | DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | CRY1, H1-5, H1-0 | OPRM1 1218/4885OPRK1 2512/4885OPRD1 966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.